UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 891

Sortiert nach

02 Results of EORTC 22991: 3D-CRT/IMRT with or without 6-month androgen deprivation therapy in localized T1b-cT2aN0M0 prostate cancer (EORTC 22991)

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (5), p.104-105

2014

Link zum Volltext

Verfügbarkeit prüfen

1.005 Solving sexual problems in movement disorders

Parkinsonism & related disorders, 2007, Vol.13, p.S30-S30

2007

Link zum Volltext

Verfügbarkeit prüfen

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

The New England journal of medicine, 2016-10, Vol.375 (15), p.1415-1424

2016

Link zum Volltext

Verfügbarkeit prüfen

1106 Cognitive study of reactivity to IPH1101 of peripheral gamma delta T lymphocytes from solid tumour patients

European journal of cancer supplements, 2009, Vol.7 (2), p.116-116

2009

Link zum Volltext

Verfügbarkeit prüfen

12.10: Two New Indices for A More Accurate Assessment of the Local Aortic Stiffness

Artery research, 2011, Vol.5 (4), p.203-203

2011

Link zum Volltext

Verfügbarkeit prüfen

1592: Patients with T0-4N0M0 Prostate Cancer Not Suitable for Local Treatment with Curative Intent (EORTC 30891): Which Subgroup Needs or does Not Need Immediate Treatment?

The Journal of urology, 2006-04, Vol.175 (4), p.513-513

2006

Link zum Volltext

Verfügbarkeit prüfen

1659: Immediate Versus Deferred Androgen Deprivation in Patients with Asymptomatic Prostate Cancer T0-4 N0-2 M0 Not Suitable for Local Definitive Treatment

The Journal of urology, 2005-04, Vol.173 (4), p.450-450

2005

Link zum Volltext

Verfügbarkeit prüfen

1746P Disease-free survival (DFS) and distant metastasis-free survival (DMFS) as surrogates for overall survival (OS) in adjuvant treatment of muscle-invasive bladder cancer (MIBC)

Annals of oncology, 2022-09, Vol.33, p.S1335-S1336

2022

Link zum Volltext

Verfügbarkeit prüfen

1BA The impact of pathological factors on long-term local control in the EORTC boost no-boost trial

European journal of cancer (1990), 2015-09, Vol.51, p.S709-S709

2015

Link zum Volltext

Verfügbarkeit prüfen

1H- 13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein

Comptes rendus de l'Académie des sciences, Série III, Sciences de la vie, 2000-10, Vol.323 (10), p.883-894

2000

Link zum Volltext

Verfügbarkeit prüfen

207 speaker UPDATE OF THREE MAJOR PHASE III RANDOMIZED TRIALS FROM THE EORTC BREAST AND RADIOTHERAPY GROUP

Radiotherapy and oncology, 2011, Vol.99, p.S80-S81

2011

Link zum Volltext

Verfügbarkeit prüfen

310: Early Stage Bladder Cancer Surveillance Does Not Improve Survival if Patients Progress to Clinical T2 Disease

The Journal of urology, 2004-04, Vol.171 (4), p.81-82

2004

Link zum Volltext

Verfügbarkeit prüfen

382: Which Subgroups of Patients are at risk to die from Prostate Cancer and Benefit from Immediate Androgen Deprivation if they are not Suitable for local Treatment with Curative intent of Newly Diagnosed Prostate Cancer T0-4 N0-2 MO (EORTC 30891)?

The Journal of urology, 2007-04, Vol.177 (4), p.127-127

2007

Link zum Volltext

Verfügbarkeit prüfen

4002 ORAL Six months versus three years concomitant and adjuvant hormonal treatment with external beam irradiation for locally advanced prostate cancer: Results of the EORTC randomized Phase III trial 22961

European journal of cancer supplements, 2007, Vol.5 (4), p.279-279

2007

Link zum Volltext

Verfügbarkeit prüfen

49 Subjective and Objective Psychophysical Olfactory Dysfunction in Men Living with HIV

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (s1), p.46-47

2023

Link zum Volltext

Verfügbarkeit prüfen

512MO Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: An analysis of the IGCCCG Update database

Annals of oncology, 2022-09, Vol.33, p.S777

2022

Link zum Volltext

Verfügbarkeit prüfen

566 GNS396 and analogues are potent new small molecules to target and kill chemotherapy-resistant subpopulation cells in acute myeloid leukemia

European journal of cancer (1990), 2014-11, Vol.50, p.183-183

2014

Link zum Volltext

Verfügbarkeit prüfen

6018 POSTER DISCUSSION EORTC 22921 Rectal Cancer Trial: Quality of Life (QoL) and Functional Outcome 5 Years After Treatment

European journal of cancer (1990), 2011, Vol.47, p.S397-S397

2011

Link zum Volltext

Verfügbarkeit prüfen

64 INTESTINAL CALCIUM UPTAKE AND TRANSPORT IN EXTRAHEPATIC BILIARY ATRESIA (EHA)

Journal of pediatric gastroenterology and nutrition, 1994-10, Vol.19 (3), p.345

1994

Link zum Volltext

Verfügbarkeit prüfen

64 INTESTINAL CALCIUM UPTAKE AND TRANSPORT IN EXTRAHEPATIC BILIARY ATRESIA (EHA)

Journal of pediatric gastroenterology and nutrition, 1994-10, Vol.19 (3), p.345-345

1994

Link zum Volltext

Verfügbarkeit prüfen

663 - Characteristics and long-term prognosis of patients with Myocardial Infarction, Non-Obtructive Coronary Arteries (MINOCA) and an inconclusive Cardiac Magnetic Resonance (CMR)

Archives of Cardiovascular Diseases Supplements, 2017-01, Vol.9 (1), p.122-122

2017

Link zum Volltext

Verfügbarkeit prüfen

664: PSA Decline from Baseline is not a Prognostic Factor for Outcome in Hormonally Treated Patients with T0-4N0M0 Prostate Cancer not Suitable for Local Treatment with Curative Intent Treated in Eortc 30891

The Journal of urology, 2006-04, Vol.175 (4), p.214-214

2006

Link zum Volltext

Verfügbarkeit prüfen

665: Baseline PSA and PSA Doubling Time Predict the Risk of Objective Progression and Death in Patients with T0-4 N0-2 M0 Prostate Cancer on Watchful Waiting

The Journal of urology, 2006-04, Vol.175 (4), p.215-215

2006

Link zum Volltext

Verfügbarkeit prüfen

A - 83 Associations between Subjective and Objective Cognition, Depression, and Quality of Life in Men Living with HIV

Archives of clinical neuropsychology, 2023-10, Vol.38 (7), p.1248-1248

2023

Link zum Volltext

Verfügbarkeit prüfen

955 ADDRESSING BARRIERS TO PATIENT ACCRUAL IN CLINICAL TRIALS: LESSONS FROM THE EORTC PROSTATE CANCER TRIAL 22043-30041

The Journal of urology, 2012-04, Vol.187 (4), p.e389-e389

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 891

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(823)
Mit Volltextzugriff
(805)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(550)
Life Sciences & Biomedicine
(427)
Humans
(359)
Female
(209)
Male
(200)
Biological And Medical Sciences
(152)
Middle Aged
(151)
Aged
(122)
Medical Sciences
(119)
Adult
(118)
Physical Sciences
(111)
Physical, Chemical, Mathematical & Earth Sciences
(85)
Physics
(85)
Physique, Chimie, Mathématiques & Sciences De La Terre
(85)
Oncology
(82)
Aérospatiale, Astronomie & Astrophysique
(80)
Space Science, Astronomy & Astrophysics
(80)
Neurosciences & Neurology
(78)
Animals
(73)
Astrophysics
(63)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(26)
European Urology
(23)
The Astrophysical Journal
(21)
European Journal Of Cancer
(15)
Physical Review Letters
(15)
Physical Review. D
(14)
Astrophysical Journal. Letters
(13)
The Lancet
(12)
The New England Journal Of Medicine
(12)
Astrophys.J
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

02 Results of EORTC 22991: 3D-CRT/IMRT with or without 6-month androgen deprivation therapy in localized T1b-cT2aN0M0 prostate cancer (EORTC 22991)

1.005 Solving sexual problems in movement disorders

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

1106 Cognitive study of reactivity to IPH1101 of peripheral gamma delta T lymphocytes from solid tumour patients

12.10: Two New Indices for A More Accurate Assessment of the Local Aortic Stiffness

1592: Patients with T0-4N0M0 Prostate Cancer Not Suitable for Local Treatment with Curative Intent (EORTC 30891): Which Subgroup Needs or does Not Need Immediate Treatment?

1659: Immediate Versus Deferred Androgen Deprivation in Patients with Asymptomatic Prostate Cancer T0-4 N0-2 M0 Not Suitable for Local Definitive Treatment

1746P Disease-free survival (DFS) and distant metastasis-free survival (DMFS) as surrogates for overall survival (OS) in adjuvant treatment of muscle-invasive bladder cancer (MIBC)

1BA The impact of pathological factors on long-term local control in the EORTC boost no-boost trial

1H- 13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein

207 speaker UPDATE OF THREE MAJOR PHASE III RANDOMIZED TRIALS FROM THE EORTC BREAST AND RADIOTHERAPY GROUP

310: Early Stage Bladder Cancer Surveillance Does Not Improve Survival if Patients Progress to Clinical T2 Disease

382: Which Subgroups of Patients are at risk to die from Prostate Cancer and Benefit from Immediate Androgen Deprivation if they are not Suitable for local Treatment with Curative intent of Newly Diagnosed Prostate Cancer T0-4 N0-2 MO (EORTC 30891)?

4002 ORAL Six months versus three years concomitant and adjuvant hormonal treatment with external beam irradiation for locally advanced prostate cancer: Results of the EORTC randomized Phase III trial 22961

49 Subjective and Objective Psychophysical Olfactory Dysfunction in Men Living with HIV

512MO Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: An analysis of the IGCCCG Update database

566 GNS396 and analogues are potent new small molecules to target and kill chemotherapy-resistant subpopulation cells in acute myeloid leukemia

6018 POSTER DISCUSSION EORTC 22921 Rectal Cancer Trial: Quality of Life (QoL) and Functional Outcome 5 Years After Treatment

64 INTESTINAL CALCIUM UPTAKE AND TRANSPORT IN EXTRAHEPATIC BILIARY ATRESIA (EHA)

64 INTESTINAL CALCIUM UPTAKE AND TRANSPORT IN EXTRAHEPATIC BILIARY ATRESIA (EHA)

663 - Characteristics and long-term prognosis of patients with Myocardial Infarction, Non-Obtructive Coronary Arteries (MINOCA) and an inconclusive Cardiac Magnetic Resonance (CMR)

664: PSA Decline from Baseline is not a Prognostic Factor for Outcome in Hormonally Treated Patients with T0-4N0M0 Prostate Cancer not Suitable for Local Treatment with Curative Intent Treated in Eortc 30891

665: Baseline PSA and PSA Doubling Time Predict the Risk of Objective Progression and Death in Patients with T0-4 N0-2 M0 Prostate Cancer on Watchful Waiting

A - 83 Associations between Subjective and Objective Cognition, Depression, and Quality of Life in Men Living with HIV

955 ADDRESSING BARRIERS TO PATIENT ACCRUAL IN CLINICAL TRIALS: LESSONS FROM THE EORTC PROSTATE CANCER TRIAL 22043-30041

Suchergebnisse filtern